ROCKVILLE, Md.--(BUSINESS WIRE)--Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of infectious diseases, announced today that John Friedman has joined its Board as an Independent Director. Mr. Friedman brings more than 30 years of venture investment experience to the Sequella Board. He is the Founding and Managing Partner of Easton Capital Investment Group. Prior to founding Easton Capital, he was a founder and Managing General Partner of Security Pacific Capital Investors, a $200-million private equity fund geared towards expansion financings and recapitalizations. Prior to joining Security Pacific, Mr. Friedman spent more than eight years at E.M. Warburg, Pincus & Co, where his last position was a Managing Director and Partner. Prior to Warburg Pincus, Mr. Friedman was an attorney with Sullivan and Cromwell.
